These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18412244)
1. Degradation of HPV20E6 by p53: Delta Np63 alpha and mutant p53R248W protect the wild type p53 mediated caspase-degradation. Fei JW; de Villiers EM Int J Cancer; 2008 Jul; 123(1):108-16. PubMed ID: 18412244 [TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cutaneous oncoprotein HPVE6 by wtp53, mutant p53R248W and ΔNp63α is HPV type dependent. Fei JW; de Villiers EM PLoS One; 2012; 7(4):e35540. PubMed ID: 22530045 [TBL] [Abstract][Full Text] [Related]
3. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544 [TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential. Elbel M; Carl S; Spaderna S; Iftner T Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453 [TBL] [Abstract][Full Text] [Related]
5. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910 [TBL] [Abstract][Full Text] [Related]
7. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients. Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190 [TBL] [Abstract][Full Text] [Related]
8. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986 [TBL] [Abstract][Full Text] [Related]
9. The role of TP53 in Cervical carcinogenesis. Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117 [TBL] [Abstract][Full Text] [Related]
10. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1. Drews CM; Case S; Vande Pol SB PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735 [TBL] [Abstract][Full Text] [Related]
11. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Munagala R; Kausar H; Munjal C; Gupta RC Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835 [TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity. Thatte J; Banks L J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500 [TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
14. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255 [TBL] [Abstract][Full Text] [Related]
15. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Nakagawa S; Huibregtse JM Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293 [TBL] [Abstract][Full Text] [Related]
16. Identification of E6AP-independent degradation targets of HPV E6. Vats A; Thatte J; Banks L J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195 [TBL] [Abstract][Full Text] [Related]
17. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633 [TBL] [Abstract][Full Text] [Related]
18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
19. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. Talis AL; Huibregtse JM; Howley PM J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376 [TBL] [Abstract][Full Text] [Related]
20. A novel dithiocarbamate derivative induces cell apoptosis through p53-dependent intrinsic pathway and suppresses the expression of the E6 oncogene of human papillomavirus 18 in HeLa cells. Li Y; Qi H; Li X; Hou X; Lu X; Xiao X Apoptosis; 2015 Jun; 20(6):787-95. PubMed ID: 25772545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]